Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines

Journal of General Internal Medicine

Volumn 31, Issue 1, 2016, Pages 52-59

  Haas, Jennifer S ^a,b,g   Sprague, Brian L ^c   Klabunde, Carrie N ^e   Tosteson, Anna N A ^d   Chen, Jane S ^a   Bitton, Asaf ^a,b   Beaber, Elisabeth F ^f   Onega, Tracy ^d   Kim, Jane J ^g   MacLean, Charles D ^c   Harris, Kimberly ^a   Yamartino, Phillip ^h   Howe, Kathleen ^c   Pearson, Loretta ^d   Feldman, Sarah ^a,b   Brawarsky, Phyllis ^a   Schapira, Marilyn M ^h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d NORRIS COTTON CANCER CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

breast cancer screening; cervical cancer screening; clinical practice guidelines; primary care; provider practice patterns

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CONTROLLED STUDY; E-MAIL; FEMALE; HEALTH CARE SYSTEM; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALPRACTICE; MAMMOGRAPHY; MEDICAL CARE; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; TIME TO TREATMENT; UTERINE CERVIX CANCER; WEB BROWSER; BREAST NEOPLASMS; CLINICAL TRIAL; EARLY CANCER DIAGNOSIS; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; STANDARDS; SURVIVAL RATE; TRENDS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 84953368389     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3449-5     Document Type: Article

References (27)

1. Feldman S. Can the new cervical cancer screening and management guidelines be simplified? JAMA Intern Med. 2014.
2. Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med. 2012;367, e31.
3. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the U.S. Preventive services task force. Ann Intern Med. 2009;151:727–737.
4. Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2009;151:716–726, W-236.
5. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med. 2009;151:738–47.
6. Smith RA, Manassaram-Baptiste D, Brooks D, Cokkinides V, Doroshenk M, Saslow D, Wender RC, Brawley OW. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: Cancer J Clin. 2014;64:30–51.
7. Practice bulletin no. 122: Breast cancer screening. Obstet Gynecol. 2011;118:372–82.
8. Lee CH, Dershaw DD, Kopans D, Evans P, Monsees B, Monticciolo D, Brenner RJ, Bassett L, Berg W, Feig S, Hendrick E, Mendelson E, D’Orsi C, Sickles E, Burhenne LW. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol: JACR. 2010;7:18–27.
9. Moyer VA. Screening for cervical cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2012.
10. ACOG. Practice bulletin number 131: Screening for cervical cancer. Obstet Gynecol. 2012;120:1222–238.
11. Yabroff KR, Zapka J, Klabunde CN, Yuan G, Buckman DW, Haggstrom D, Clauser SB, Miller J, Taplin SH. Systems strategies to support cancer screening in U.S. primary care practice. Cancer Epidemiol Biomarkers Prev. 2011;20:2471–479.
12. Sack K. Republicans Say Cancer Screening Guidelines Portend Medical Rationing. In: New York Times. New York: New York Times; 2009.
13. Saraiya M, Berkowitz Z, Yabroff KR, Wideroff L, Kobrin S, Benard V. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending? Arch Intern Med. 2010;170:977–85.
14. Meissner HI, Klabunde CN, Han PK, Benard VB, Breen N. Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United States. Cancer. 2011;117:3101–11.
15. Corbelli J, Borrero S, Bonnema R, McNamara M, Kraemer K, Rubio D, Karpov I, McNeil M. Physician adherence to U.S. Preventive services task force mammography guidelines. Womens Health Issues. 2014;24:e313–9.
16. Corbelli J, Borrero S, Bonnema R, McNamara M, Kraemer K, Rubio D, Karpov I, McNeil M. Differences among primary care physicians’ adherence to 2009 ACOG guidelines for cervical cancer screening. J Womens Health (Larchmt). 2014;23:397–403.
17. Bodenheimer T, Pham HH. Primary care: current problems and proposed solutions. Health Aff. 2010;29:799–805.
18. Onega T, Beaber EF, Sprague BL, Barlow WE, Haas JS, Tosteson AN, Schnall MD, Armstrong K, Schapira MM, Geller B, Weaver DL, Conant EF. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer. 2014;120(19):2955–64.
19. Meissner HI, Klabunde CN, Breen N, Zapka JM. Breast and colorectal cancer screening: U.S. primary care physicians’ reports of barriers. Am J Prev Med. 2012;43:584–9.
20. Han PK, Klabunde CN, Breen N, Yuan G, Grauman A, Davis WW, Taplin SH. Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians. Med Care. 2011;49:139–48.
21. Smith AA, Kepka D, Yabroff KR. Advanced practice registered nurses, physician assistants and cancer prevention and screening: a systematic review. BMC Health Serv Res. 2014;14:68.
22. Yabroff KR, Klabunde CN, Yuan G, McNeel TS, Brown ML, Casciotti D, Buckman DW, Taplin S. Are physicians’ recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med. 2011;26:177–84.
23. Han PK, Klabunde CN, Noone AM, Earle CC, Ayanian JZ, Ganz PA, Virgo KS, Potosky AL. Physicians’ beliefs about breast cancer surveillance testing are consistent with test overuse. Med Care. 2013;51:315–23.
24. O’Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014;160:145.
25. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011;155:481–92.
26. 2012 Physician specialty data book; 2012.
27. McLeod CC, Klabunde CN, Willis GB, Stark D. Health care provider surveys in the United States, 2000–2010: a review. Eval Health Prof. 2013;36:106–26.